Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer.
Saved in:
| Title: | Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer. |
|---|---|
| Authors: | Kverneland AH; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Pedersen M; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Westergaard MCW; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Nielsen M; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Borch TH; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Olsen LR; Section for Bioinformatics, DTU Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.; Center for Genomic Medicine, Copenhagen University Hospital, Copenhagen, Denmark., Aasbjerg G; Section for Bioinformatics, DTU Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark., Santegoets SJ; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., van der Burg SH; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Milne K; Deeley Research Centre, BC Cancer, Victoria, Canada., Nelson BH; Deeley Research Centre, BC Cancer, Victoria, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, Canada., Met Ö; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Donia M; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Svane IM; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. |
| Source: | Oncotarget [Oncotarget] 2020 Jun 02; Vol. 11 (22), pp. 2092-2105. Date of Electronic Publication: 2020 Jun 02 (Print Publication: 2020). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: eCollection Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32547707 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kverneland+AH%22">Kverneland AH</searchLink>; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Pedersen+M%22">Pedersen M</searchLink>; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Westergaard+MCW%22">Westergaard MCW</searchLink>; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Nielsen+M%22">Nielsen M</searchLink>; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Borch+TH%22">Borch TH</searchLink>; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Olsen+LR%22">Olsen LR</searchLink>; Section for Bioinformatics, DTU Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.; Center for Genomic Medicine, Copenhagen University Hospital, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Aasbjerg+G%22">Aasbjerg G</searchLink>; Section for Bioinformatics, DTU Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.<br /><searchLink fieldCode="AU" term="%22Santegoets+SJ%22">Santegoets SJ</searchLink>; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Burg+SH%22">van der Burg SH</searchLink>; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Milne+K%22">Milne K</searchLink>; Deeley Research Centre, BC Cancer, Victoria, Canada.<br /><searchLink fieldCode="AU" term="%22Nelson+BH%22">Nelson BH</searchLink>; Deeley Research Centre, BC Cancer, Victoria, Canada.; Department of Medical Genetics, University of British Columbia, Vancouver, Canada.<br /><searchLink fieldCode="AU" term="%22Met+Ö%22">Met Ö</searchLink>; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Donia+M%22">Donia M</searchLink>; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.<br /><searchLink fieldCode="AU" term="%22Svane+IM%22">Svane IM</searchLink>; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101532965%22">Oncotarget</searchLink> [Oncotarget] 2020 Jun 02; Vol. 11 (22), pp. 2092-2105. <i>Date of Electronic Publication: </i>2020 Jun 02 (<i>Print Publication: </i>2020). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Impact+Journals%22">Impact Journals </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101532965 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1949-2553 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2219492553%22">19492553 </searchLink><i>NLM ISO Abbreviation: </i>Oncotarget <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32547707 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.18632/oncotarget.27604 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2092 Titles: – TitleFull: Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kverneland AH – PersonEntity: Name: NameFull: Pedersen M – PersonEntity: Name: NameFull: Westergaard MCW – PersonEntity: Name: NameFull: Nielsen M – PersonEntity: Name: NameFull: Borch TH – PersonEntity: Name: NameFull: Olsen LR – PersonEntity: Name: NameFull: Aasbjerg G – PersonEntity: Name: NameFull: Santegoets SJ – PersonEntity: Name: NameFull: van der Burg SH – PersonEntity: Name: NameFull: Milne K – PersonEntity: Name: NameFull: Nelson BH – PersonEntity: Name: NameFull: Met Ö – PersonEntity: Name: NameFull: Donia M – PersonEntity: Name: NameFull: Svane IM IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 06 Text: 2020 Jun 02 Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1949-2553 Numbering: – Type: volume Value: 11 – Type: issue Value: 22 Titles: – TitleFull: Oncotarget Type: main |
| ResultId | 1 |